0

526075

VINRKLB

img img img img
No Data Available

REKVINA LABORATORIES LTD. Share Price Update

As of the latest trading session, REKVINA LABORATORIES LTD. share price is currently at ₹22.3, which is up by ₹0.42 from its previous closing. Today, the stock has fluctuated between ₹22.30 and ₹22.31. Over the past year, REKVINA LABORATORIES LTD. has achieved a return of [-]%. In the last month alone, the return has been 214.97%.

Investment Returns

Over 1 Month [-]% Over 3 Months 0.00% Over 6 Months 0.00% Over 1 Year 0.00%
demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

REKVINA LABORATORIES LTD. fundamentals


  • Market cap (Cr)

    [-]

  • P/E Ratio (TTM)

    [-]

  • Beta

    [-]

  • Book Value / share

    [-]

  • Return on equity

    [-]%

  • EPS (TTM)

    [-]

  • Dividend yield

    [-]%

  • Net profit/quarter (Cr)

    [-]

info icon alternate text
  • Market cap (Cr)

    13.40

  • P/E Ratio (TTM)

    -57.18

  • Beta

    -1.73

  • Book Value / share

    -1.24

  • Return on equity

    0.00%

  • EPS (TTM)

    0.00

  • Dividend yield

    [-]%

  • Net profit/quarter (Cr)

    -0.12

info icon alternate text

REKVINA LABORATORIES LTD. Financials

  • Key Results

  • Key Ratios

  • Balance sheet

  • Cash Flow

  • Competition

info-icon

Revenue

Net income

Particulars DEC 2025 (Values in Cr)
Revenue 0.35
Operating Expense 0.47
Net Profit -0.12
Net Profit Margin (%) -34.28
Earnings Per Share (EPS) -0.21
EBITDA -0.12
Effective Tax Rate (%) 0.00
Particulars SEP 2025 (Values in Cr)
Revenue 0.20
Operating Expense 0.23
Net Profit -0.03
Net Profit Margin (%) -15.00
Earnings Per Share (EPS) 0.06
EBITDA -0.03
Effective Tax Rate (%) 0.00
Particulars JUN 2025 (Values in Cr)
Revenue 0.00
Operating Expense 0.04
Net Profit -0.04
Net Profit Margin (%) 0.00
Earnings Per Share (EPS) 0.05
EBITDA -0.04
Effective Tax Rate (%) 0.00
Particulars MAR 2025 (Values in Cr)
Revenue 0.00
Operating Expense 0.04
Net Profit -0.04
Net Profit Margin (%) 0.00
Earnings Per Share (EPS) -0.07
EBITDA -0.04
Effective Tax Rate (%) 0.00
Particulars DEC 2024 (Values in Cr)
Revenue 0.00
Operating Expense 0.02
Net Profit -0.02
Net Profit Margin (%) 0.00
Earnings Per Share (EPS) -0.04
EBITDA -0.02
Effective Tax Rate (%) 0.00
Particulars MAR 2025 (Values in Cr)
Revenue 0.00
Operating Expense 0.14
Net Profit -0.14
Net Profit Margin (%) 0.00
Earnings Per Share (EPS) -0.23
EBITDA -0.14
Effective Tax Rate (%) 0.00
Particulars MAR 2024 (Values in Cr)
Revenue 0.00
Operating Expense 0.02
Net Profit -0.02
Net Profit Margin (%) 0.00
Earnings Per Share (EPS) -0.03
EBITDA -0.02
Effective Tax Rate (%) 0.00
Particulars MAR 2023 (Values in Cr)
Revenue 0.00
Operating Expense 0.00
Net Profit 0.00
Net Profit Margin (%) 0.00
Earnings Per Share (EPS) 0.00
EBITDA 0.00
Effective Tax Rate (%) 0.00
Particulars MAR 2022 (Values in Cr)
Revenue 0.00
Operating Expense 0.08
Net Profit -0.08
Net Profit Margin (%) 0.00
Earnings Per Share (EPS) -0.13
EBITDA -0.08
Effective Tax Rate (%) 0.00
Particulars MAR 2021 (Values in Cr)
Revenue 0.00
Operating Expense 0.06
Net Profit -0.06
Net Profit Margin (%) 0.00
Earnings Per Share (EPS) -0.10
EBITDA -0.06
Effective Tax Rate (%) 0.00
Particulars MAR 2025 (Values in Cr)
Book Value / Share -0.55
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.00
EBITDA Margin 0.00
Particulars MAR 2024 (Values in Cr)
Book Value / Share -0.01
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.00
EBITDA Margin 0.00
Particulars MAR 2023 (Values in Cr)
Book Value / Share 0.02
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 4.00
EBITDA Margin 0.00
Particulars MAR 2022 (Values in Cr)
Book Value / Share 0.02
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.00
EBITDA Margin 0.00
Particulars MAR 2021 (Values in Cr)
Book Value / Share 0.15
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.00
EBITDA Margin 0.00
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 0.02
Total Assets 0.03
Total Liabilities 0.03
Total Equity -0.33
Share Outstanding 0
Price to Book Ratio 0.00
Return on Assets (%) -421.84
Return on Capital (%) 160.73
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 0.00
Total Assets 0.20
Total Liabilities 0.20
Total Equity 0.00
Share Outstanding 0
Price to Book Ratio 0.00
Return on Assets (%) -8.13
Return on Capital (%) -19
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 0.00
Total Assets 0.20
Total Liabilities 0.20
Total Equity 0.01
Share Outstanding 0
Price to Book Ratio 0.00
Return on Assets (%) -0.34
Return on Capital (%) -0.74
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 0.00
Total Assets 0.19
Total Liabilities 0.19
Total Equity 0.01
Share Outstanding 0
Price to Book Ratio 0.00
Return on Assets (%) -41.01
Return on Capital (%) -567.49
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 0.00
Total Assets 0.24
Total Liabilities 0.24
Total Equity 0.09
Share Outstanding 0
Price to Book Ratio 26.47
Return on Assets (%) -26.45
Return on Capital (%) -69.18
Particulars MAR 2025 (Values in Cr)
Net Income -0.13
Cash from Operations -0.19
Cash from Investing 0.00
Cash from Financing 0.20
Net change in Cash 0.01
Free Cash Flow -0.19
Particulars MAR 2024 (Values in Cr)
Net Income -0.01
Cash from Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00
Net change in Cash 0.00
Free Cash Flow 0.00
Particulars MAR 2023 (Values in Cr)
Net Income 0.00
Cash from Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00
Net change in Cash 0.00
Free Cash Flow 0.00
Particulars MAR 2022 (Values in Cr)
Net Income -0.07
Cash from Operations -0.03
Cash from Investing 0.03
Cash from Financing 0.00
Net change in Cash 0.00
Free Cash Flow -0.03
Particulars MAR 2021 (Values in Cr)
Net Income -0.06
Cash from Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00
Net change in Cash 0.00
Free Cash Flow 0.00
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 28.58 12.37 1.48 219.02 23.12 / 52.00
BLISS GVS PHARMA LTD 217.80 20.82 2.03 2304.08 105.05 / 225.00
CIPLA LTD 1330.85 22.61 3.26 107503.49 1283.00 / 1672.20
FERMENTA BIOTECH LIMITED 310.90 10.34 2.34 915.01 219.00 / 399.00
GLAXOSMITHKLINE PHARMA LT 2593.90 43.69 25.73 43942.23 1968.00 / 3515.95
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 28.58 23.24 3.98 219.02 23.12 / 52.00
AMRUTAJAN HEALTH LTD 632.15 31.61 5.34 1827.59 548.05 / 789.95
ASTRAZENECA PHARMA IND LT 8878.75 106.70 27.78 22196.88 6501.60 / 10653.05
BLISS GVS PHARMA LTD 217.80 29.67 2.08 2304.08 105.05 / 225.00

REKVINA LABORATORIES LTD. shareholding pattern

Holding

58.7%
41.29%
Name Shares Category
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)

REKVINA LABORATORIES LTD. Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
22.30 1.91 redarrow
red-green-graph indicator
16 Bearish
0 Bullish
  • 5 Days 21.00
  • 26 Days 14.30
  • 10 Days 19.00
  • 50 Days 10.90
  • 12 Days 18.30
  • 100 Days 8.40
  • 20 Days 15.70
  • 200 Days 7.30
21.88 PIVOT

First Support

21.88

First Resistance

21.88

Second Support

21.88

Second Resistance

21.88

Third Support

21.88

Third Resistance

21.88

RSI

0.00

ADX

100.00

MACD

3.98

Williams % R

-0.09

Commodity Channel Index (CCI)

119.53

Date

2026-02-13

Week

4569.00

Same Day

3715.00

Month

2243.00

1 Year

-1.73

3 Year

-1.83

Over 1 Month

214.97%

down

Over 1 Year

0.00%

down

Over 3 Months

0.00%

down

Over 3 Years

0.00%

down

Over 6 Months

0.00%

down

Over 5 Years

39.84%

down

REKVINA LABORATORIES LTD. Corporate Actions

Ex-Date Old FV NEW FV Record Date
30 Apr 2014 10.0 5.0 02 May 2014

Top Gainers

REKVINA LABORATORIES LTD. Share Price

Rekvina Labs Limited was incorporated on 1st November 1988. From a small domestic company at inception in middle of 80's, Rekvina has grown formidably to be an integrated, Indian pharmaceutical company with sales in excess of Rs 20 Crore. It is registered in England and Wales as a Public Limited Company. The Company is a Quality producer of Pharmaceutical formulations for its customer as per their specific requirements. It provide contract research and manufacturing services to customers.

The Company is mainly engaged in manufacturing and marketing of pharmaceutical products. It presently operates into one business segment i.e. Copper Extrusion. The Company had launched a new product 'REKSEAL', a tissue adhesive for wound closure from the market in 1999-2000. Though there was persistent recessionary trend in the pharmaceutical industry there is a decrease in the turnover of the Company which affected the. net worth of the Company adversely.

In 2019-20, there was an overall slowdown in the economy. The Company incurred losses over a couple of years. The Company is focusing on strengthening its core business of manufacturing and marketing formulations. Research and Development (R&D) initiatives have been accelerated to improve cost competitiveness and ensure compliance with global regulatory requirements. Cost optimization, efficient resource utilization, and strong management control are being emphasized across all operations.

Parent organization Indian Private
NSE symbol [-]
Founded 1988
stock

Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Current Share Price of Rekvina Labs Ltd?

Answer Field

Rekvina Labs Ltd share price is for NSE ₹ 0.00 & for BSE ₹ 22.30 as on Feb 13 2026 03:15 PM.

What is the Market Cap of Rekvina Labs Ltd Share?

Answer Field

The market cap of Rekvina Labs Ltd for NSE ₹ 0.00 & for BSE ₹ 13.40 as on Feb 13 2026 03:15 PM.

What is the 52 Week High and Low of Rekvina Labs Ltd?

Answer Field

The 52 Week High and Low of Rekvina Labs Ltd for NSE is ₹ 0.00 and ₹ 0.00 and for BSE is ₹ 22.31 and ₹ 6.75.

What is 1 year return for Rekvina Labs Ltd?

Answer Field

The 1 year returns on the stock has been 0.00%.

What is the P/E Ratio of Rekvina Labs Ltd Share?

Answer Field

As on Feb 13 2026 03:15 PM the price-to-earnings (PE) ratio for Rekvina Labs Ltd share is -57.18.

What is the PB ratio of Rekvina Labs Ltd Share?

Answer Field

As on Feb 13 2026 03:15 PM, the price-to-book (PB) ratio for Rekvina Labs Ltd share is -1.24.

How to Buy Rekvina Labs Ltd Share?

Answer Field

You can trade in Rekvina Labs Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Rekvina Labs Ltd Share on Bajaj Broking App?

Answer Field

To buy Rekvina Labs Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Rekvina Labs Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

close-image

Get Free Demat Account*

+91
close-img

Authorise with OTP

Enter the 4-Digit OTP sent to
edit
OTP expires in 00:59